无与透静脉双腔心脏起器:来自AVEIR DR覆盖的现实证据与证据开发研究
Monica Lo1, Anish K Amin2, Marcin Kowalski3,4
1Arkansas Heart Hospital, Little Rock, Arkansas, USA.
Journal of cardiovascular electrophysiology
|January 16, 2026
概括
在AVEIR DR无心脏起器 (LP) 的6个月内,与输血式心脏起器 (TP) 相比,与设备相关的并发症和重新干预的次数较少,短期结果类似.
科学领域:
- 心血管医学 心血管医学
- 医疗器械 医疗器械
- 健康 结果 研究 研究 结果
背景情况:
- AVEIR DR是一款创新的双室无心脏起器 (LP),利用植入物到植入物通信实现连续心房同步.
- 评估AVEIR DR LP的早期现实安全性和比较有效性至关重要.
研究的目的:
- 为了比较AVEIR DR无心脏起器 (LP) 与传统的双透静脉起器 (TP) 的安全性和有效性.
- 这项研究旨在评估两种心脏起器类型之间的并发症,再干预,心力衰竭住院和死亡率.
主要方法:
- 使用医疗保险服务费索赔数据对新生无心脏起器 (LP) 和输血心脏起器 (TP) 患者进行比较分析.
- 评估的结果包括30天和6个月的并发症,重复干预,心力衰竭住院和全因死亡率,并根据患者人口统计和并发症进行调整.
主要成果:
- 虽然30天的结果是可比的,但与TP相比,AVEIR DR LP表现出与设备相关的并发症 (2.0%对3.9%) 和整体6个月的并发症 (4.1%对6.9%) 显著降低.
- 无心脏起器组也显示了减少6个月设备重新干预 (2.1%对4.3%) 和设备相关并发症 (2.8%对5.9%).
- 在LP和TP组之间,在6个月死亡率或心力衰竭住院期间没有发现显著差异.
结论:
- 尽管无心脏起器队列的并发症负担较高,但AVEIR DR LP在六个月后在与设备相关的并发症和重新干预方面表现出卓越的安全概况.
- 该研究表明,AVEIR DR LP与TP的短期安全性和死亡率相似,在减少与设备相关的问题方面具有显著的长期优势.
相关概念视频
01:21Cardiac Catheterization II: Right Heart Catheterization
839
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
839
01:24Cardiac Catheterization III: Left Heart Catheterization
597
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
597
01:23Cardiopulmonary Resuscitation III: AED Use
547
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
547
01:30Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364